Study of AT-752 in Healthy Subjects

• Status: Recruiting
• Trial end date: 2021-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-752 in healthy subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Atea Pharmaceuticals, Inc.

Criteria

Inclusion Criteria:

1. Body mass index (BMI) of 18-29 kg/m2

2. Must agree to use protocol-specified methods of contraception

3. Negative pregnancy test

4. Willing to comply with the study requirements and to provide written informed consent

Exclusion Criteria:

1. Pregnant or breastfeeding

2. Abuse of alcohol or drugs

3. Use of other investigational drugs within 30 days of dosing

4. Other clinically significant medical conditions